Author | Bob Valamehr, PhD | OncLive

Author | Bob Valamehr, PhD

Articles

Advantages of Off-the-Shelf CAR NK Therapy in B-Cell Malignancies

May 01, 2020

Video

Bob Valamehr, PhD, chief development officer at Fate Therapeutics, discusses the advantages of off-the-shelf CAR NK therapy in B-cell malignancies.

x